Trial Profile
A Phase 1/2 dose-escalation study of INCB01158 in Solid tumors.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Numidargistat (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2017 New trial record